MEGHAN FREED: Open Payments
NPI 1386308906 · LEMOYNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $142 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $149 |
| Neurelis, Inc. | 1 | $125 |
| GENZYME CORPORATION | 3 | $72 |
| Celltrion USA Inc. | 1 | $30 |
Products named: REZDIFFRA, VALTOCO, DUPIXENT, VEGZELMA.
Industry payments across PA — which companies pay providers there.
